Cash/Burn From SEC Filing For Period:
ESPERION is passionately committed to developing and commercializing oral, LDL-C lowering therapies for patients with hypercholesterolemia.
Click drug data to see upcoming trial info and prior data
Drug | Disease
Stage | Exp Date
See What The Community Is Saying - Click To See Full Post